NGM Biopharmaceuticals In...

1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
4.42M 55.33M 77.88M 87.37M 103.54M 108.67M 77.14M 85.59M
2.22M 5.98M 7.9M 163.97M 129.25M n/a n/a n/a
2.2M 49.35M 69.98M -76.6M -25.71M 108.67M 77.14M 85.59M
-146.55M -166.25M -120.69M -103.83M -49.34M -4.31M -17.43M -8.36M
9.32M 3.71M 420K 1.94M 6.69M 3.62M 2.36M 1.81M
-142.38M -162.67M -120.33M -102.49M -42.8M -493K -15.22M -6.42M
-142.38M -159.09M -113.83M -93.99M -28.5M -493K -14.16M -6.92M
36.73M 40.52M 36.87M 27.23M 23.63M 17.27M 14.83M 11.85M
112.01M 181.07M 161.71M 163.97M 129.25M 95.71M 79.74M 82.11M
-234K -132K -60K -593K -147K 199K -152K 133K
148.74M 221.58M 198.58M 191.2M 152.88M 112.98M 94.57M 93.95M
n/a 3.71M n/a n/a n/a n/a n/a n/a
-1.1M n/a n/a n/a n/a n/a n/a n/a
150.96M 221.58M 198.58M 191.2M 152.88M 112.98M 94.57M 93.95M
n/a -3.58M -6.51M -8.49M -14.3M 3.82M -1.06M 500K
82.5M 79.95M 77.09M 68.48M 50.3M 64.99M 53.65M 53.65M
82.5M 79.95M 77.09M 68.48M 50.3M 64.99M 53.65M 53.65M
-1.73 -1.99 -1.48 -1.37 -0.57 -0.01 -0.26 -0.13
-1.73 -1.99 -1.48 -1.37 -0.57 -0.01 -0.26 -0.13
-144.33M -166.25M -120.69M -103.83M -49.34M 2.91M -10.98M -4.83M
n/a -158.95M n/a n/a n/a n/a n/a n/a
2.22M 4.04M 6.09M 6.55M 7.61M 7.22M 6.44M 3.53M